ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 750 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 1000 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - neisseria meningitidis group a polysaccharide; neisseria meningitidis group c polysaccharide; neisseria meningitidis group w - 135 polysaccharide; neisseria meningitidis group y polysaccharide - אבקה וממס להכנת תמיסה להזרקה - neisseria meningitidis group y polysaccharide 5 mcg; neisseria meningitidis group w - 135 polysaccharide 5 mcg; neisseria meningitidis group c polysaccharide 5 mcg; neisseria meningitidis group a polysaccharide 5 mcg - other meningococcal monovalent purified polysaccharides antigen - other meningococcal monovalent purified polysaccharides antigen - nimenrix is indicated for active immunisation of individuals from the age of 12 months and above against invasive meningococcal diseases caused by neisseria meningitidis group a, c, w-135 and y.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - phenytoin sodium - קפסולות - phenytoin sodium 100 mg - phenytoin - phenytoin - treatment of epilepsy.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - varenicline as tartrate - טבליות מצופות פילם - varenicline as tartrate 0.5 mg - varenicline - varenicline - champix is indicated as an aid to smoking cessation treatment adults over 18 years of age.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - varenicline as tartrate - טבליות מצופות פילם - varenicline as tartrate 1 mg - varenicline - varenicline - champix is indicated as an aid to smoking cessation treatment adults over 18 years of age.

ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd - exametazime 0.5 mg/vial - powder for solution for injection - technetium (99m-tc) compounds - regional cerebral blood flow scintigraphy- leucocytes labelling.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - durvalumab - תמיסה לאינפוזיה - durvalumab 50 mg/ml - durvalumab

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - durvalumab - תמיסה לאינפוזיה - durvalumab 50 mg/ml - durvalumab

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - tafamidis as meglumine - קפסולות ג'לטין רכות - tafamidis as meglumine 12.2 mg - tafamidis